Sat May 30 10:06:09 SGT 2015  
SINGAPORE
HAIR™
    Hair loss, Singapore (SG)

Hair loss, Singapore (SG)

Summary

Hair loss, Singapore (SG) @singaporehair_com: Hair loss treatment clinic, Singapore

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hair loss, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Case of alopecia areata accompanied by polymyalgia rheumatica
Thu, 28 May 2015 00:00:00 +0100 | The Journal of Dermatology
(Source: The Journal of Dermatology)

Hairless Up‐Regulates Tgf‐β2 Expression via Down‐Regulation of miR‐31 in the Skin of “Hairpoor” (HrHp) Mice
Tue, 26 May 2015 00:00:00 +0100 | Journal of Cellular Physiology
In this study, we found that 64 miRNAs were differentially expressed between the skin of HrHp/HrHp and wild type mice at P7 using miRNA‐microarray analysis and miR‐31 displayed the most reduced expression in HrHp/HrHp skin. In vivo observation and investigation using an in vitro reporter expression system revealed that miR‐31 and pri‐miR‐31 were consistently down‐regulated in the HR over‐expressed condition. In addition, we found that the transforming growth factor β 2 (Tgf‐β2), a known catagen inducer, is the putative target of miR‐31. Furthermore, Tgf‐β2 level was also increased in HR over‐expressed keratinocyte and HrHp/HrHp mice. These study results suggest that HR controls Tgf‐β2 expression via regulation of miR‐31, thus causing abnormal hair cycle in HrH...

Contact immunotherapy‐resistant alopecia areata totalis/universalis reactive to topical corticosteroid
Mon, 25 May 2015 00:00:00 +0100 | The Journal of Dermatology
(Source: The Journal of Dermatology)

Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract
Mon, 25 May 2015 00:00:00 +0100 | Australasian Journal of Dermatology
ConclusionsThe topical application of S. repens extract could be an alternative treatment in male pattern baldness in male patients who do not want or cannot tolerate the side‐effects of standard medications, but the use of a concentrated S. repens product beyond 4 weeks may be necessary for sustained efficacy. (Source: Australasian Journal of Dermatology)

Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.
Mon, 25 May 2015 00:00:00 +0100 | The Australasian Journal of Dermatology
CONCLUSIONS: The topical application of S. repens extract could be an alternative treatment in male pattern baldness in male patients who do not want or cannot tolerate the side-effects of standard medications, but the use of a concentrated S. repens product beyond 4 weeks may be necessary for sustained efficacy.

A Workshop for Educating Nurses to Address Sexual Health in Patients With Breast Cancer.
Sun, 24 May 2015 12:22:57 +0100 | Clinical Journal of Oncology Nursing
Authors: Smith A

Management of dermatologic toxicities.
Sat, 23 May 2015 19:12:03 +0100 | Journal of the National Comprehensive Cancer Network : JNCCN
Authors: Lacouture ME

Outcomes of Ovarian Germ Cell Tumors: Ten Years of Experience at the Brazilian National Cancer Institute
Sat, 23 May 2015 08:34:42 +0100 | International Journal of Gynecological Cancer
Conclusions: Our study confirms the effectiveness of BEP regimen and the great prognosis for patients with OGCTs. Advanced-stage and persistent disease configured as an important risk factor for survival. The chemotherapy regimen was associated with significant but manageable toxicity. (Source: International Journal of Gynecological Cancer)

The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax)
Sat, 23 May 2015 00:00:00 +0100 | Annals of Oncology
Conclusion

Effectiveness of 308-nm Excimer Laser Therapy in Treating Alopecia Areata, Determined by Examining the Treated Sides of Selected Alopecic Patches
Fri, 22 May 2015 10:31:37 +0100 | Dermatology
Conclusion: The 308-nm excimer laser has a therapeutic effect on AA, which is proven by photograph and phototrichogram analysis by a side-by-side comparison.Dermatology (Source: Dermatology)